We analyzed the viral C2-V4 envelope diversity, glycosylation patterns, and d S /d N ratios of plasma HIV-1 in an attempt to better understand the complex interaction between viral quasispecies and the host-selective pressures pre-and post-HAART. Phylogenetic analysis of the envelope gene of five patients revealed monophyletic clustering in patients with higher CD4 + T cell counts and sequence intermingling in those with lower CD4 + T cells in relation to the stage of HAART. Our analyses also showed clear shifts in N-linked glycosylation patterns in patients with higher CD4 + T cells, suggesting possible distinct immunological pressures pre-and post-HAART. The relative preponderance of synonymous/nonsynonymous changes in the envelope region suggested a positive selection in patients with higher CD4 + T cells, whereas lack of evidence for positive selection was found in the patients with lower CD4 + T cells. An exception to the last analysis occurred in the only patient who reached complete viral suppression, maybe due to drug pressure exerted over the pol gene that may obscure the immune pressure/selection at the envelope in this analysis. All these indications may suggest that even when HAART generates viral suppression, quasispecies evolve in the envelope gene probably resulting from host-selective pressure. D
Introduction
Human immunodeficiency virus type 1 (HIV-1) replication is characterized by a high degree of viral sequence variation, primarily due to mutations introduced by the error-prone reverse transcriptase that leads into development of distinct viral quasispecies. Therefore, even in a single individual, the virus exists as highly related, although genetically distinct quasispecies (Kuiken et al., 1993; Lorenzo et al., 2004; Malim and Emerman, 2001; Nowak et al., 1991) . Phylogenetic methodologies have been extensively used to reconstruct an evolutionary history of these diverse viral quasispecies (DeBry et al., 1993; Hillis et al., 1994; Lorenzo et al., 2001 Lorenzo et al., , 1996 Ou et al., 1992) . A critical consequence of HIV-1 variability has been determined to be high degree of viral sequence diversity in the envelope gene that results in the co-receptor usage shift. HIV-1 co-receptor usage has been shown to be an important determinant of viral tropism and pathogenesis. During acute infection, the virus uses CCR5 co-receptor (R5) in vivo, whereas later in the infection, CXCR4-utilizing virus (X4) appears mixed with R5 quasispecies (Connor et al., 1997; Stevenson, 2003) . The emergence of X4 utilizing strains presages cell depletion and clinical deterioration (Philpott et al., 2001; Stevenson, 2003) . Genetic analysis of patient viral populations such as the study presented here has been extensively used to gain information on the pathogenesis of the infection as well as to clarify in vivo evolution of HIV-1 (Delwart et al., 1997; Shankarappa et al., 1999) . Nevertheless, the exact nature and significance of the mechanisms that govern intra-host evolution and pathogenesis remain largely unknown.
The HIV evasive ability to counter the immune system has also been associated in part with both the rapid variability of the HIV envelope protein sequence and the masking of epitopes by glycosylation (Nara et al., 1991; Quiñones-Kochs et al., 2002; Wei et al., 2003) . The Nglycosylation sites are significant for the binding of carbohydrates to the viral envelope to mask viral protein epitopes from the immune response, and thus enabling the HIV-1 to escape neutralization. Indeed, one of the most important functions of N-linked glycosylation is protection of otherwise accessible neutralization epitopes of the viral envelope from neutralizing antibodies (Nab) (Bolmstedt et al., 1996) . Recently, it has been shown that mutations in Nlinked glycosylation sites rendered a neutralization antibody sensitive virus to be completely resistant to pre-existing neutralizing antibodies (Stipp et al., 2000; Wei et al., 2003) . This pattern of escape led these researchers to postulate an bevolving glycan shieldQ mechanism of neutralization escape in which selected changes in glycosylation patterns prevent Nab but not receptor binding (Wei et al., 2003) . This evolving glycosylation pattern of the envelope gene represents a new mechanism contributing to HIV-1 persistence in the face of a dynamic antibody repertoire. Although the number of N-linked glycosylation sites varies with the strain of HIV-1, there are usually 24 such potential sites in the envelope gene (Quiñones-Kochs et al., 2002) , and their somewhat conserved locations suggest generally strong and persistent selective pressures. Clear changes in these glycosylation sites will suggest shifts in immune pressure (Kemal et al., 2003; Wei et al., 2003) .
The majority of positive selection in the HIV-1 has been found to occur in the envelope region of the genome, as opposed to the gag or pol region (Choisy et al., 2004) . Positive selection in the HIV-1 env gene has been demonstrated by comparisons of the abundance of nonsynonymous (d N ) and synonymous (d S ) pairwise variability in the DNA sequence (Bonhoeffer et al., 1995; Nielsen, 1999) . The relative ratio of nonsynonymous and synonymous changes in the HIV env gene seems to be generated by a balance between selective pressure placed on the virus quasispecies mainly by the immune system, which favors amino acid diversification, and the negative selection against missense mutation that breaks the structural constraints of the functional Env protein (Anastassopoulou et al., 2003; Shankarappa et al., 1999) .
Patients under HAART have been extensively followed for the emergence of drug-resistance by sequencing pol and identifying the associated mutations (Demeter et al., 1998; Gallant et al., 2003; Little et al., 2002; Tirado et al., 2004; Unal et al., 1996) . However, there is only limited information available regarding the evolution of other viral genes in patients on HAART. Interestingly, the envelope gene, one of the most immunogenic regions of the HIV-1, is linked to numerous viral characteristics including transmission, viral entry, co-receptor usage, tropism, and immune escape (Rangel et al., 2003) . However, few research studies have been focused in the envelope gene of the HIV-1 after the advent of HAART. In an effort to improve our understanding of the complex interaction between viral quasispecies and the host-selective immune pressure, we analyzed the env gene viral diversity, glycosylation patterns, and selective pressures in plasma pre-and post-HAART.
Results
We sequenced and analyzed HIV-1 C2-V4 env of 148 clones from plasma virus in five patients who were sampled before receiving any antiretroviral drug therapy (time 1) and after achieving viral suppression due to the therapeutic regimen (time 2) (Fig. 1) . Patients A and B were clinically classified as categories A and B (CDC, 1993) , respectively, with N400 CD4 + T cell counts; and patients C, D, and E were category C with CD4 + T cell counts b200 cells/ml blood, at the time of enrollment. All participants exhibited viral suppression 6-10 months after commencement of HAART. Patients A and E showed emergence of rebounding virus after initial suppression (time 3), whereas patients B, C, and D maintained undetectable plasma viral loads throughout study (Table 1) . Viral sequences at second time point for patient A are unavailable for this study due to the limited volume of plasma accessible for the amplification of HIV-1 RNA. We observed T-tropic variants during advanced disease of patients C and E, in agreement with Kreisberg et al. (2001) and Schuitemaker et al. (1992) . Utilizing most stringent genotyping method (Jensen et al., 2003) , we observed disappearance of these T-tropic variants after HAART, in agreement with Philpott et al. (2001) and Skrabal et al. (2003) .
Phylogenetic reconstructions pre-and post-HAART
Phylogenetic analysis by the NJ method of the plasma quasispecies in the five HIV-1-infected participants showed monophyletic groups that were separated from nucleotide sequences of the other patients with 100% bootstrap values, excluding the possibility of laboratory contamination (Fig.  2 ). There was a correlation between the clustering tendency of sequences and the CD4 + T cell count profile in four of five patients. NJ phylogenetic reconstruction provided evidence of clear temporal clustering of the C2-V4 env sequences preand post-HAART in patients A, B, and C. On the other hand, sequence intermingling was observed in patients D and E in the time points prior to and subsequent to antiretroviral therapy. These sequences, however, were related enough to cluster within sequences from the same person. Conversely, patient C showed temporal phylogenetic clustering even with 79 CD4 + T lymphocyte counts, which is the highest of the clinically C-categorized participants. These observations agree with recent findings of Kemal et al. (2003) , who reported intermingled envelope sequences of plasma and genital tract of females with CD4 + T cell depletion.
Bottleneck evolution in the HIV-1 env C2-V4 region
We analyzed 480 bp of sequence spanning the C2-V4 env region for the five patients. To determine the presence or absence of bottleneck evolution (Ibanez et al., 2000) , the sequence diversity was determined as the mean of the nucleotide distances in each time point per patient, shown in Table 2 . All patients showed V 4% sequence diversity within each time point. Highly homogeneous virus (b1% nucleotide distance) was found in plasma of patients B and C before receiving HAART. We found a slight convergence in the clone sequences after HAART-induced viral suppression (time 2), in comparison to the treatment-naive time points (time 1). More homogeneous virus (b2% nucleotide diversity) appeared in those patients that showed partial failure to the therapeutic regimen (patients A and E), after suppressing the virus below or very close to the detection limit. Patient E showed a resistant virus that was slightly more homogeneous when compared to the baseline virus, whereas in the patient A, the genomic restriction was fourfold. This difference could be attributed to the degree of suppression attained by the patients. Although it seems insignificant that patient A reached viral loads b50 copies/ml during suppressive HAART and patient E reached a viral load of 68 copies/ml, this numerical difference could be important to set hypothetical thresholds for the occurrence of bottleneck evolution in the HIV-1 envelope.
Synonymous and nonsynonymous nucleotide substitution changes in HIV-1 envelope before HAART and during suppressed plasma viremia
We determined selection pressure on HIV-1 quasispecies by analyzing the synonymous (silent) and nonsynonymous (amino acid-changing) nucleotide substitution patterns. Positive selection is indicated by the dominance of the rate of nonsynonymous nucleotide substitutions over the rate of synonymous substitutions. The mean values of nucleotide substitutions per synonymous site (d S ) and nonsynonymous site (d N ) of all pairwise sequence comparisons between time-points (Frost et al., 2001) were calculated as shown in Table 3 . We found b1 mean values in patients with higher CD4 + T cell counts (patients B and C), suggesting positive selection, whereas lack of evidence for positive selection was found in patients D and E (those with lower CD4 + T cell counts). In an attempt to validate this observation, we performed nonparametric statistical treatment by grouping patients according to their CD4 + T cell counts and their continuous suppressive status (thus, patient A was excluded from this analysis). As anticipated, we found statistical correlation between CD4 + T cell counts and positive selection (see Table 4 ).
Contrary to the expected results, patient A, who is the only participant who achieved complete viral suppression (b50 copies/ml), showed lack of positive selection at the level of envelope gene (as well as patients D and E), probably due to the drug pressure exerted over the pol gene that may eclipse the immune pressure/selection at the envelope.
Changes in the C2-V4 env N-glycosylation patterns pre-and post-HAART Changes in the N-linked glycosylation sites suggest shifts in terms of the HIV-1 specific immune responses. The C2-V4 region contains more than 12 potential N-linked glycosylation sites (see Fig. 3 ). As expected, our analyses showed that in patients with higher CD4 + T cell counts (patients A-C), there was a clear shift in terms of glycosylation sites before and during HAART, suggesting selective immune pressures. Conversely, in patients E and D, there was indication of poor selective immune pressure patients, consistent with their lower CD4 + T cell counts.
Discussion
The present study characterized different quasispecies of the virus in five HIV-infected individuals. The gene we analyzed codes for part of the envelope, which is not the target of HAART regimes of our cohort, implying that we are primarily measuring the result of a selective pressure other than HAART. Our results demonstrate the possibility of involvement of immune pressure in the selection of viral variants that has been shown by several studies. However, this is the first indication that during HAART viral evolution is influenced by not only drug pressure but also immune pressure in patients with higher CD4 + counts. This conclusion is based on unambiguous difference in the envelope sequence in patients having higher CD4 + T cell counts compared to those who had lower CD4 + T lymphocyte counts. Our conclusion is also supported by possible correlation between CD4 + T cell counts in phylogenetic clustering, d S /d N ratio (an indicator of positive selection), and changes N-linked glycosylation sites.
Phylogenetic analyses of these plasma sequences revealed monophyletic clustering of pre-and post-HAART in patients A, B, and C (higher CD4 + T cell counts). However, patients D and E (lowest CD4 + T cell counts) did not cluster in relation to time points. These results suggest that although all patients experienced a noticeable viral suppression due to HAART's pressure over the pol gene, only the ones with the higher CD4 + T lymphocytes were able to mount an effective/selective immune pressure over the envelope gene. This new selective pressure was able to generate a related, although clearly distinct viral population within few months. This finding is at least, in principle, consistent with a recent report that showed women with monophyletic HIV-1 genomic clusters per compartment (plasma and vaginal) had consistently higher CD4 + T counts, while those with lower CD4 + T cell counts display intermingled quasispecies between compartments (Kemal et al., 2003) . In addition, our findings are in general agreement with recent studies suggesting that specific immune responses to HIV (and SIV in model system) are inversely correlated with disease progression, and that the presence and help of CD4 + T cells is essential to the disease control (Garber et al., 2004; Kaech and Ahmed, 2003; Moir et al., 2003; Rosenberg et al., 1997) .
Our analyses also revealed clear shifts in glycosylation sites in patients A, B, and C. The number of glycosylation sites is conserved among different HIV strains. Sequence changes altering potential glycosylation sites have been shown to play an extremely important role in providing the capacity to escape from immune recognition (Back et al., 1994; Cheng-Mayer et al., 1999; Wei et al., 2003) . Differences in glycosylation sites suggest the evolution of two Diversity was determined by using MEGA with Kimura 2-parameter. SD, standard deviation. * P value. separate sets of sequences under distinct immune pressures before and after HAART. Just as in the previous analysis, patients D and E (lowest CD4 + counts) did not show clear shifts in glycosylation sites suggesting lack of an effective immune pressure on the env gene.
In addition, patients B and C in this study showed a d S /d N ratio of b1, suggesting continued positive selection in these patients, whereas d S /d N ratio (N1) in patients D and E suggested lack of positive selection. This analysis measures the variations of the synonymous per nonsynonymous ratio (d S /d N ), which provides a measure at the molecular level of the selection intensity among amino acid sites (Anastassopoulou et al., 2003; Nielsen and Yang, 1998) . It has been suggested that changes in the strength of the immune response may not result in predictable changes in the d S /d N ratio if the selection coefficient is on the same order of magnitude as the effective population size. Nevertheless, observations of temporal changes in the d S /d N ratio alone may still provide partial information about the status of the immune system (Frost et al., 2001; Nielsen, 1999) . The reason why patient A did not show the expected positive selection pressure is not fully understood. However, patient A is the only patient in our study that achieved a viral load b50 and developed fourfold decrease in genomic diversity from pre-to post-HAART. At the same time patient A, together with patient E, is one of the two patients that exhibited emergence of rebounding virus, and the only in which we were unable to study the lowest viral load after therapy started. The time point analyzed in this case is one in which the viral load is increasing during HAART, which normally indicates the selection of a resistant virus. This drug selection is indeed applied to the pol gene, and we believe it may be eclipsing the immune pressure/selection applied at the env gene.
Based on the diversity values of our patients' viral sequences before and after HAART, we were not able to observe any clear viral genomic diversity restriction or bottleneck evolution in HIV-1 env gene except in patient A. This might be attributed to the fact that other patients never achieved undetectable viremia (b50 copies/ml), which might be important for narrowing the viral diversity in patients on HAART. Another potentially important implication of the present study is that establishment of HAART resistance may be followed by faster virus rebound in patients with low CD4 + T cell counts than in patients with high CD4 + T cell counts. The future attempts should be directed towards characterization of the virus emerging after a prolonged and complete suppression, which may help in identification of source of virus replication during HAART, and whether viral rebound is faster in patients with low CD4 + T cell counts.
Materials and methods

Study subjects
Five HIV-1 infected informed-consenting individuals, aged from 34 to 56 years were enrolled for the study. Blood samples were collected from all five patients before commencement of antiretroviral therapy. They achieved and maintained almost complete viral suppression after the initiation of the antiretroviral regimen. In this study, we analyzed samples pre-HAART (Time 1), during plasma viral suppression (Time 2) and occasionally during the virological failure to the therapy (Time 3). Plasma HIV-1 viral load measurement was carried out using the standard (detection limit, 400 copies/ml) and ultrasensitive (detection limit, 50 copies/ml) Amplicor HIV-1 Monitor test (Roche Molecular Systems, Inc., Branchburg, NJ). CD4 + T cells were quantified by flow cytometry analyses using a FACSScan (BD Biosciences, San Jose, CA). The clinical characteristics of the patients are shown in Table 1 .
Genetic characterization of HIV-1 env C2-V4 from plasma HIV-1 RNA was isolated from plasma by using the QIAmp Viral RNA Mini Kit (QIAGEN, Inc, Valencia, CA) following the manufacturer's indications. For the analysis of plasma HIV-1 RNA with viral loads b200 copies/ml, 3 ml of plasma was applied to the column of the same kit. In order to amplify the HIV-1 C2-V4 env region, nested PCR was performed by using the OneStep RT-PCR Kit and HotStar Taq DNA Polymerase (QIAGEN, Inc) with the external primer pair ED12 and ED31 (5V -AGTGCTTCCTGCTGCT-CCCAAGAACCCAAG-3V and 5VCCTCAGTCATTAC ACCAGGCCTGTCCAAAG-3Vrespectively) and the internal primer pair CV3-R and CV3-F (5V -TGATGGGAGGGG-TATACATT-3V and 5V -CTGTTAAATGGCAGTCTAGC-3V respectively). The final amplicon (525 bp) was electrophoresed with a low molecular weight marker in 1.2% agarose, stained with ethidium bromide, and visualized under UV light for determination of molecular weight. Cloning and sequencing of HIV-1 C2-V4 envelope gene from plasma PCR products were ligated and cloned according to the TOPO TA Cloning Kit protocol (Invitrogen, Carlsbad, CA). Plasmid DNA was purified by using QIAprep Spin Miniprep columns (QIAGEN, Inc.) . A total of 148 clones were sequenced with M13 primers using Big-Dye terminator chemistry according to manufacturer's recommendations in an Applied Biosystems 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA).
Sequence analysis
All nucleotide sequences analyses were carried out on a 480 bp fragment of the env gene spanning the C2-V4 region. Nucleotide sequences were aligned with BioEdit version 5.0.9 (Hall, 1999) and later hand edited. Fig. 3 . Graph of the fraction of N-linked glycosylation sites at each position in the alignment of amino acid sequences from patients A-E. Potential Nglycosylation sites were determined by using the N-Glycosite tool from Los Alamos HIV sequence database, http://hiv-web.lanl.gov. Phylogenetic reconstructions were generated by the neighbor-joining (NJ) method (with Kimura two-parameter model and a transition/transversion ratio of 2.0) in 1000 bootstrapped data sets as implemented in the MEGA version 2.1 (Kumar et al., 2001 ). The final graphical output was created with TreeView. Pairwise nucleotide sequence distance was computed by using MEGA. The frequencies of synonymous substitutions per synonymous site (d S ) and nonsynonymous per nonsynonymous site (d N ) were estimated by using the SNAP tool from the Los Alamos HIV sequence database, http://hivweb.lanl.gov. Potential N-linked glycosylation sites were determined by using the N-glycosite tool from the Los Alamos HIV Sequence database. Data were subjected to nonparametric statistical treatment using Wilcoxon signed rank test included in the SPSS Version 12.0 software package (SPSS, Inc., Chicago).
